Here’s how we played the massive rebound in AI stocks this week
AI stocks came roaring back this week as investors worked through another wave of corporate earnings and a surprisingly weak...
Eli Lilly and Co
Stocks making the biggest moves premarket: SpaceX, AMD, Eli Lilly, Disney & more
Check out the companies making the biggest moves premarket: SpaceX — The Elon Musk-led rocket company fell 11% after releasing...
CVS blows past estimates, hikes guidance as insurance unit continues to improve
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its insurance unit...
S&P 500 futures are little changed after massive rally lifts index to fresh record: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., August 4, 2026....
Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage
A FedEx worker walks past his truck in the North Beach neighborhood on June 23, 2026 in San Francisco, California.Heather...
Stocks making the biggest moves premarket: Lockheed Martin, Tesla, Alphabet & more
Check out the companies making the biggest moves premarket: Tesla — Shares were down nearly 6% after the company reported...
Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production
U.S. President Donald Trump signs an executive order on researching the effects of psychedelic drugs in medical treatment for veterans,...
Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more
Check out the companies making the biggest moves in midday trading: Abbott Laboratories – The maker of Ensure nutrition shakes...
Stocks making the biggest moves premarket: UnitedHealth, TSMC, GE Aerospace, J.B. Hunt & more
Check out the companies making the biggest moves in premarket trading: UnitedHealth — Shares rose more than 7% in early...
Jim Cramer calls out buying opportunities in this 'vicious' market rotation
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
Here are Tuesday's biggest analyst calls: SpaceX, Nvidia, Apple, Figma, Shopify, First Solar, Ferrari & more
Here are Tuesday's biggest calls on Wall Street: Deutsche Bank upgrades First Solar to buy from hold Deutsche said shares...
Here are the 3 big things we're watching in the stock market this week
We're entering the quiet before the earnings storm. The Independence Day-shortened trading week is behind us. So is the June...
Medicare will start covering obesity drugs for the first time. Here's what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity...
Chip stocks rebound, and Goldman racks up a series of M&A wins
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time...
America can't get enough of protein. The dairy industry can't keep up
Whitebalance.space | E+ | Getty ImagesAmerica's "protein-maxxing" obsession is stressing the dairy industry.Whey protein concentrate, once considered a cheap byproduct...
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Injection pens for the weight loss treatment Wegovy, manufactured by Novo Nordisk A/S, on display during a news conference in...
Estrogen patches are hard to find, and it may not be resolved any time soon
Woman applying estrogen patch during hormone therapy.Halfpoint Images | Moment | Getty ImagesEstrogen patches are in short supply as demand...
What this biotech's volatile stock price tells you about the weight loss market right now
Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher...
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are only months into introducing GLP-1 pills and navigating huge changes in how patients pay for weight-loss drugs. Even...
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare...
